Vignesh Sankar
About Vignesh Sankar
Vignesh Sankar is a Clinical Research Fellow at the National Institutes of Health, specializing in the study of alcohol addiction. He leads research projects that explore clinical and behavioral differences in alcoholic individuals and investigates the role of oxytocin in this context.
Work at National Institutes of Health
Vignesh Sankar has been employed as a Clinical Research Fellow at the National Institutes of Health (NIH) since 2016. He works in Bethesda, Maryland, where he is involved in various clinical research initiatives. His role includes the recruitment and screening of participants for clinical studies. Sankar focuses on translational and clinical studies aimed at discovering new medications for alcohol addiction. He conducts research under the guidance of Dr. Leggio, who leads the NIH section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology.
Education and Expertise
Vignesh Sankar earned a Bachelor of Science (B.Sc.) degree in Physiology and Neurobiology from the University of Maryland, studying from 2012 to 2016. His educational background provides a solid foundation for his research in clinical settings, particularly in the areas of psychoneuroendocrinology and neuropsychopharmacology. This academic experience has equipped him with the necessary knowledge and skills to contribute effectively to his current research endeavors.
Background in Clinical Research
Prior to his role at the NIH, Vignesh Sankar worked as an ED/Trauma Scribe at ScribeAmerica from 2014 to 2016. During this time, he was based at Suburban Hospital in Bethesda, Maryland. His experience in this position allowed him to gain valuable insights into clinical settings and patient care, which have informed his current research focus on alcohol addiction and related behavioral studies.
Research Focus and Projects
Sankar leads a project that examines clinical and behavioral differences between treatment-seeking and non-treatment-seeking alcoholic individuals. His research investigates the role of oxytocin and the NCATS2 protocol in the context of alcoholism. These projects aim to enhance the understanding of alcohol addiction and contribute to the development of effective treatment strategies.